Do Larger Health Insurance Subsidies Benefit Patients or Producers? Evidence from Medicare Advantage
Author(s) -
Marika Cabral,
Michael Geruso,
Neale Mahoney
Publication year - 2018
Publication title -
american economic review
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 16.936
H-Index - 297
eISSN - 1944-7981
pISSN - 0002-8282
DOI - 10.1257/aer.20151362
Subject(s) - subsidy , economics , payment , health insurance , legislature , government (linguistics) , medicare advantage , market power , monetary economics , monopoly , health care , finance , microeconomics , market economy , economic growth , linguistics , philosophy , archaeology , history
A central question in the debate over privatized Medicare is whether increased government payments to private Medicare Advantage (MA) plans generate lower premiums for consumers or higher profits for producers. Using difference‑in‑differences variation brought about by a sharp legislative change, we find that MA insurers pass through 45 percent of increased payments in lower premiums and an additional 9 percent in more generous benefits. We show that advantageous selection into MA cannot explain this incomplete pass‑through. Instead, our evidence suggests that market power is important, with premium pass‑through rates of 13 percent in the least competitive markets and 74 percent in the most competitive. (JEL G22, H51, I11, I13, I18)
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom